TY - JOUR
T1 - Cost drivers and feasibility of a hospital-at-home programme for geriatric care in northeastern Mexico
T2 - a retrospective observational study
AU - González Ochoa, Jesús Sebastian
AU - Garza-Silva, Arnulfo
AU - González Peña, Omar Israel
AU - Romero-Ibarguengoitia, Maria Elena
AU - Fernández-Chau, Iván Francisco
AU - Villarreal Parra, Diana L.
AU - Torres Valerio, Nadia D.
AU - Sanz-Sánchez, Miguel Ángel
AU - Hughes García, Melissa
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025/4/2
Y1 - 2025/4/2
N2 - Objective The primary objective was to evaluate factors influencing the cost of a 'hospital at home' (HAH) for geriatric patients in a Northeastern Mexican hospital. Secondarily to evaluate the per capita global cost-effectiveness compared with traditional hospital care. Design This retrospective analysis examined the costs incurred by geriatric patients in an HAH programme from February to December 2022 Setting We collected data from clinical records and assessed medication and procedure costs through the hospital's financial department. Costs for traditionally hospitalised patients were reviewed for comparison. Participants Subjects of both genders aged 70 and older who were treated in HAH during 2022 and hospitalised subjects with the same age and gender treated in the same period. Intervention: NA Primary and secondary outcome measures Primary outcome: factors that influence costs in HAH. Secondary, global per capita cost comparison between HAH and hospital care. Results We examined the expenses associated with 416 home visits to 49 patients in the HAH programme. The main factors influencing the programme's overall cost were medical care and procedure-related disorders (β=0.333, p=0.002), sleep-regulators (β=0.561, p<0.001), laxatives (β=0.330, p=0.001) and anticoagulants (β=0.228, p=0.025). The HAH programme's per capita cost was three times lower compared with that of traditional hospital care and resulted in a 40% reduction in hospitalisation days. Conclusions This study highlights that the main factors influencing the HAH programme's costs include medical care and procedure-related disorders, as well as medication extensively used in the elderly population. Additionally, we demonstrated the cost-effectiveness of the HAH programme, which produces substantial savings and is a financially viable alternative to traditional hospital care.
AB - Objective The primary objective was to evaluate factors influencing the cost of a 'hospital at home' (HAH) for geriatric patients in a Northeastern Mexican hospital. Secondarily to evaluate the per capita global cost-effectiveness compared with traditional hospital care. Design This retrospective analysis examined the costs incurred by geriatric patients in an HAH programme from February to December 2022 Setting We collected data from clinical records and assessed medication and procedure costs through the hospital's financial department. Costs for traditionally hospitalised patients were reviewed for comparison. Participants Subjects of both genders aged 70 and older who were treated in HAH during 2022 and hospitalised subjects with the same age and gender treated in the same period. Intervention: NA Primary and secondary outcome measures Primary outcome: factors that influence costs in HAH. Secondary, global per capita cost comparison between HAH and hospital care. Results We examined the expenses associated with 416 home visits to 49 patients in the HAH programme. The main factors influencing the programme's overall cost were medical care and procedure-related disorders (β=0.333, p=0.002), sleep-regulators (β=0.561, p<0.001), laxatives (β=0.330, p=0.001) and anticoagulants (β=0.228, p=0.025). The HAH programme's per capita cost was three times lower compared with that of traditional hospital care and resulted in a 40% reduction in hospitalisation days. Conclusions This study highlights that the main factors influencing the HAH programme's costs include medical care and procedure-related disorders, as well as medication extensively used in the elderly population. Additionally, we demonstrated the cost-effectiveness of the HAH programme, which produces substantial savings and is a financially viable alternative to traditional hospital care.
UR - http://www.scopus.com/inward/record.url?scp=105001842230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105001842230&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2024-093056
DO - 10.1136/bmjopen-2024-093056
M3 - Article
AN - SCOPUS:105001842230
SN - 2044-6055
VL - 15
JO - BMJ Open
JF - BMJ Open
IS - 4
M1 - e093056
ER -